Health

NAC (N-Acetyl Cysteine)

N-Acetyl Cysteine - the glutathione precursor with evidence across psychiatric, respiratory, and addiction applications.

For project work, advisory, or technical questions, send a concise note.

Share what you're working on and what success looks like. I read every message and respond within a few days.

NAC is a modified form of the amino acid cysteine. It's been around for decades - initially as a mucolytic and as the standard treatment for paracetamol (acetaminophen) overdose. More recently, it has picked up a substantial evidence base in psychiatry, addiction medicine, and neuroprotection. The reason it keeps showing up across so many fields comes down to two mechanisms: it replenishes glutathione, and it modulates glutamate signalling.

The Glutathione System

Glutathione is the body's principal intracellular antioxidant - the primary renewable free radical scavenger within neurons. The problem is that glutathione itself doesn't cross the blood-brain barrier well. NAC does. Once absorbed, NAC provides cysteine, the rate-limiting precursor for glutathione synthesis. More cysteine available means more glutathione produced.

Why does this matter for the brain? Glutathione depletion - particularly within mitochondria - increases neuronal susceptibility to oxidative damage. Neurons are metabolically expensive cells. They consume disproportionate amounts of oxygen, generate large quantities of reactive oxygen species, and depend heavily on antioxidant defences to survive. When glutathione drops, neurons become vulnerable.

NAC also has direct antioxidant properties independent of glutathione. It scavenges free radicals on its own, though this is secondary to its role as a glutathione precursor.

Glutamate Modulation

This is the mechanism that makes NAC interesting for psychiatry and addiction. NAC acts on the cystine-glutamate antiporter (system Xc−), a transporter on glial cells that exchanges extracellular cystine for intracellular glutamate. By increasing extracellular cystine (NAC is converted to cystine), NAC stimulates this antiporter, which increases extrasynaptic glutamate release.

Extrasynaptic glutamate activates presynaptic metabotropic glutamate receptors (mGluR2/3), which act as autoreceptors - they reduce further synaptic glutamate release. The net effect is a normalisation of glutamate tone, particularly in the nucleus accumbens.

This is directly relevant to addiction and compulsive behaviour. Dysregulated glutamate signalling in the nucleus accumbens is a feature of substance use disorders, OCD, and some presentations of bipolar disorder. By restoring glutamate homeostasis, NAC can reduce craving and compulsive behaviour without acting on dopamine directly.

Neuroprotective Mechanisms

Beyond glutathione and glutamate, NAC has several additional neuroprotective actions documented in preclinical models:

  • Anti-apoptotic effects: Complex modulation of neurotrophic factor signalling within neurons, including blocking activation of JNK (c-Jun amino-terminal kinase) in trophin-deprived cells
  • Signalling pathway modulation: Uncouples NGF activation of MAPK from Ras signalling
  • Peripheral nerve protection: In peripheral nerve injury models, NAC demonstrates both motor and sensory neuroprotective capacity, working primarily through glutathione replenishment rather than direct receptor modulation
  • Cell-cycle regulatory potential: May modulate neuronal survival pathways

Psychiatric Evidence

Addiction Applications

This is arguably where NAC's evidence is most compelling.

The common thread across addiction applications: NAC doesn't block the high or create aversion. It recalibrates the glutamate system so that the compulsive drive is dampened. It's not an anti-craving medication in the way naltrexone is - it's more of a background normaliser.

Respiratory Uses

NAC is an established mucolytic. It breaks disulphide bonds in mucus glycoproteins, reducing mucus viscosity. It's been used for decades in COPD, cystic fibrosis, and bronchitis. This is an FDA-approved indication, unlike the psychiatric uses which remain off-label.

Other Applications

  • Liver protection: NAC is the standard of care for paracetamol toxicity - it replenishes hepatic glutathione stores and prevents liver necrosis. This is its best-established clinical use.
  • Fertility: May improve oocyte quality in PCOS through reduction of oxidative stress.
  • Immune function: Reduces inflammatory cytokines. Was studied during COVID-19 for its anti-inflammatory and mucolytic properties.
  • Exercise recovery: Reduces oxidative damage from intense exercise, though practical benefit for athletes is debated.

Dosing

  • Standard dose: 600mg once or twice daily
  • Psychiatric applications: 1200–2400mg/day, typically divided into two doses
  • Timing: Works on both empty stomach and with food. Empty stomach may increase absorption slightly.
  • Form: Capsules or powder. The powder has a strong sulphur smell and taste - capsules are more practical for most people.
  • Stacking: Often combined with selenium (a cofactor for glutathione peroxidase) and alpha-lipoic acid (which recycles glutathione).

Side Effects

Generally mild. The most common are GI upset and nausea, particularly at higher doses. Rare: excessive thinning of mucus (which can be problematic in patients with already thin secretions).

NAC may interact with nitroglycerin - it potentiates the hypotensive effect. Patients on nitrates should avoid NAC or use it under medical supervision.

Limitations

NAC is not a panacea, despite appearing in literature across dozens of conditions. Important caveats:

  • Individual variation is significant. Not everyone responds, and the reasons aren't well understood.
  • Most trials are short. The typical study duration is 8–24 weeks. Long-term continuous use data is sparse.
  • The glutathione increase is indirect. Not all of NAC's clinical effects can be attributed to glutathione - some may be via glutamate modulation, direct antioxidant activity, or other pathways.
  • Biofilm concerns at high doses. There's some theoretical concern that NAC can disrupt microbial biofilms, potentially releasing trapped pathogens. Clinical significance is unclear.
  • Quality varies. As a supplement, NAC is not regulated to pharmaceutical standards. Third-party tested products (NSF, USP) are worth the premium.

When NAC Is Useful vs. When It's Not

References

  • Rehman MU, et al. Neuroprotection by natural products in peripheral nerve injury models. J Cell Biochem. 2019;120(3):3745-3753.
  • Dean O, Giorlando F, Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci. 2011;36(2):78-86.
  • Berk M, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia - a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008;64(5):361-368.
  • Gray KM, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169(8):805-812.
  • Berk M, et al. N-acetyl cysteine for depressive symptoms in bipolar disorder - a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008;64(6):468-475.
  • Smaga I, et al. N-acetylcysteine as a new prominent approach for treating psychiatric disorders. Br J Pharmacol. 2021;178(13):2569-2594.